SPY382.88-1.36 -0.35%
DIA309.97-1.90 -0.61%
IXIC13,543.06+12.15 0.09%

Roth Capital Initiates Coverage On Applied Genetic Tech with Buy Rating, Announces $25 Price Target

Roth Capital analyst Zegbeh Jallah initiates coverage on Applied Genetic Tech (NASDAQ:AGTC) with a Buy rating and a $25 price target.

Benzinga · 01/28/2020 11:27

Roth Capital analyst Zegbeh Jallah initiates coverage on Applied Genetic Tech (NASDAQ:AGTC) with a Buy rating and a $25 price target.